Advances in CRISPR-Cas systems for human bacterial disease

Area of Science:

• Microbiology
• Molecular Biology
• Genetics

Background:

• CRISPR-Cas systems are prokaryotic adaptive immune mechanisms enabling targeted DNA cleavage.
• These systems are crucial for genome editing, involving CRISPR-associated genes and RNA-guided DNA targeting.
• CRISPR-Cas is broadly classified into Class 1 (multi-subunit) and Class 2 (single effector) systems.

Purpose of the Study:

• To explore the applications of CRISPR-Cas technology in combating antimicrobial resistance (AMR).
• To highlight CRISPR-Cas's role in targeting antibiotic resistance genes (ARGs) and resensitizing bacteria to antibiotics.
• To discuss the utility of CRISPR-based tools in diagnostics and genetic modification for infectious diseases like tuberculosis (TB).

Main Methods:

• Utilizing CRISPR-Cas systems for targeted DNA cleavage to disarm bacteria.
• Employing CRISPR-Cas3 to degrade plasmids carrying resistance genes.
• Leveraging Cas endonucleases' collateral cleavage activity for sensitive pathogen detection.

Main Results:

• CRISPR technology effectively targets ARGs in ESKAPE pathogens, resensitizing them to antibiotics.
• CRISPR-Cas3 demonstrates efficacy in degrading resistance-conferring plasmids.
• CRISPR-based diagnostics provide highly sensitive detection of pathogens.

Conclusions:

• CRISPR-Cas systems represent a transformative approach to addressing AMR.
• These systems offer precise genetic tools for infectious disease research and management.
• CRISPR technology holds significant potential for enhancing diagnostics and developing novel therapeutic strategies against resistant bacteria.